MacroGenics announced the final overall survival (OS) results of the SOPHIA Phase 3 study in adult patients with metastatic HER2-positive breast cancer. The study compared…
A privately-held Cambridge, MA-based biotech called Strang Therapeutics recently secured funding from two Phase 1 Small Business Innovation Research (SBIR) grants from the National Cancer…
An African American principal investigator, Tarsha Jones, PhD recently received a five-year, $772,525 Career Development Award from the National Institutes of Health (NIH) K01 Career…
Diagnosed with stage four triple breast cancer, a woman in Scotland and her family now raise funds so that this mother of two can participate…
A University of California, Davis (UC Davis) employed at the UC Davis Comprehensive Cancer Center received $600,000 from a Susan G. Komen® grant to develop…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
